Otsuka Holdings Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OTSKY research report →
Price Chart
About the company
Otsuka Holdings Co. , Ltd. engages in the management of its group companies which are in the pharmaceuticals business.
- CEO
- Makoto Inoue
- IPO
- 2012
- Employees
- 37,758
- HQ
- Tokyo, TKY, JP
Get TickerSpark's AI analysis on OTSKY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $38.80B
- P/E
- 15.20
- Fwd P/E
- 0.10
- PEG
- 18.96
- P/S
- 2.34
- P/B
- 1.90
- EV/EBITDA
- 9.22
- Div Yield
- 1.46%
- Gross Margin
- 71.78%
- Op Margin
- 17.26%
- Net Margin
- 15.46%
- ROE
- 13.24%
- ROIC
- 9.52%
Latest fiscal year · YoY change
- Revenue
- $2.59T+11.1%
- Gross Profit
- $1.86T+11.2%
- Op Income
- $432.43B
- Net Income
- $380.76B+11.0%
- EPS
- $359.19+13.4%
- OCF Growth
- +19.3%
- FCF Growth
- +47.0%
- 52W High
- $40.92
- 52W Low
- $25.30
- 50D MA
- $37.28
- 200D MA
- $34.14
- Beta
- -0.05
- RSI (14)
- 48
- Avg Volume
- 45.63K
No earnings-call transcripts are available for OTSKY yet.
- Free Float
- 41.9%
- Shares Outstanding
- 1.05B
- Float Shares
- 440.72M
of shares held by institutions
10 13F filers
Congressional trading
Senate and House stock disclosures for OTSKY, newest first.
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Aristotle Capital Management, LLC | 2.94M | ▼ 143.38K |
| Boston Common Asset Management, LLC | 82.86K | ▲ 82.86K |
| Hantz Financial Services, Inc. | 70.56K | ▼ 7.43K |
| Rhumbline Advisers | 45.79K | ▲ 7.91K |
| Gamma Investing LLC | 9.26K | ▲ 353 |
| Westside Investment Management, Inc. | 1.42K | 0 |
| First Command Advisory Services, Inc. | 943 | ▲ 754 |
| Salomon & Ludwin, LLC | 723 | ▼ 39 |
| Pnc Financial Services Group, Inc. | 131 | ▲ 29 |
| Ima Wealth, Inc. | 79 | ▲ 30 |
Held by 4 ETFs
Biggest fund positions in OTSKY by dollar value.
Our OTSKY coverage
Recent articles, reports, and earnings notes.
No research on OTSKY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OTSKY report →Critical Survey: Inhibikase Therapeutics (NASDAQ:IKT) and Otsuka (OTCMKTS:OTSKY)
defenseworld.net · Oct 1
Otsuka, Ionis' experimental ALS drug meets main goal in late-stage study
reuters.com · Sep 22
Otsuka Announces Transformative Phase 3 FUSION Results for Ulefnersen, Bringing the FUS-ALS Community Closer to a Potential Targeted Treatment
businesswire.com · Sep 22
Otsuka Holdings Co., Ltd. (OTSKY) Discusses 24-Month eGFR Results of Sibeprenlimab in IgA Nephropathy from Phase III VISIONARY Study Prepared Remarks Transcript
seekingalpha.com · Aug 6
Otsuka Holdings Co., Ltd. (OTSKY) Q2 2026 Earnings Call Prepared Remarks Transcript
seekingalpha.com · Aug 5
Aristotle Global Equity Advisory Q2 2026 Portfolio Review
seekingalpha.com · Jul 30
Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America
prnewswire.com · Jul 9
AstraZeneca (OTCMKTS:AZNCF) versus Otsuka (OTCMKTS:OTSKY) Financial Review
defenseworld.net · Apr 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.